• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Med Res . Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review

tetano

Editor, Senior Moderator
Eur J Med Res


. 2021 Jun 8;26(1):51.
doi: 10.1186/s40001-021-00524-8.
Characterization of SARS-CoV-2 different variants and related morbidity and mortality: a systematic review


SeyedAhmad SeyedAlinaghi[SUP] 1 [/SUP], Pegah Mirzapour[SUP] 1 [/SUP], Omid Dadras[SUP] 2 [/SUP], Zahra Pashaei[SUP] 3 [/SUP], Amirali Karimi[SUP] 4 [/SUP], Mehrzad MohsseniPour[SUP] 1 [/SUP], Mahdi Soleymanzadeh[SUP] 5 [/SUP], Alireza Barzegary[SUP] 6 [/SUP], Amir Masoud Afsahi[SUP] 7 [/SUP], Farzin Vahedi[SUP] 4 [/SUP], Ahmadreza Shamsabadi[SUP] 8 [/SUP], Farzane Behnezhad[SUP] 9 [/SUP], Solmaz Saeidi[SUP] 10 [/SUP], Esmaeil Mehraeen[SUP] 11 [/SUP], Shayesteh Jahanfar[SUP] 12 [/SUP]



Affiliations

Abstract

Introduction: Coronavirus Disease-2019 (SARS-CoV-2) started its devastating trajectory into a global pandemic in Wuhan, China, in December 2019. Ever since, several variants of SARS-CoV-2 have been identified. In the present review, we aimed to characterize the different variants of SARS-CoV-2 and explore the related morbidity and mortality.
Methods: A systematic review including the current evidence related to different variants of SARS-CoV-2 and the related morbidity and mortality was conducted through a systematic search utilizing the keywords in the online databases including Scopus, PubMed, Web of Science, and Science Direct; we retrieved all related papers and reports published in English from December 2019 to September 2020.
Results: A review of identified articles has shown three main genomic variants, including type A, type B, and type C. we also identified three clades including S, V, and G. Studies have demonstrated that the C14408T and A23403G alterations in the Nsp12 and S proteins are the most prominent alterations in the world, leading to life-threatening mutations.The spike D614G amino acid change has become the most common variant since December 2019. From missense mutations found from Gujarat SARS-CoV-2 genomes, C28854T, deleterious mutation in the nucleocapsid (N) gene was significantly associated with patients' mortality. The other significant deleterious variant (G25563T) is found in patients located in Orf3a and has a potential role in viral pathogenesis.
Conclusion: Overall, researchers identified several SARS-CoV-2 variants changing clinical manifestations and increasing the transmissibility, morbidity, and mortality of COVID-19. This should be considered in current practice and interventions to combat the pandemic and prevent related morbidity and mortality.

Keywords: COVID-19; Characterizations; Genomic diversity; SARS-CoV-2; Strains; Variants.
 
Back
Top Bottom